Cite

    Wu, Y. et al. (2017). 5‐Aminoimidazole‐4‐carboxamide 1‐β‐D‐ribofuranoside reduces intimal hyperplasia of tissue engineering blood vessel by inhibiting phenotype switch of vascular smooth muscle cell. Journal of biomedical materials research. 105 (4), pp. 744-752. [Online].